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T cell mediated autoimmunity may be important in
inflammatory skin disease, but target autoantigens have
not previously been described. In studies aimed at
defining T cell epitopes, aqueous extracts of normal
facial and plantar stratum corneum have consistently
been found to induce potent proliferation of peripheral
blood mononuclear cells from normal donors and
patients with inflammatory skin disease, giving stimula-
tion indices up to 80. Potent stimulation was seen
with both autologous and allogeneic stratum corneum
extracts. Because of the presence of inhibitory material,
demonstration of the stimulatory activity was critically
dependent on extract concentration, and was facilitated
by short-term pulsing of cultures with extract. The
proliferation of cells purified from peripheral blood
mononuclear cells by immunomagnetic beads and
immunophenotyping of cell lines generated from peri-
pheral blood mononuclear cells, confirmed the T cell
The skin is a highly immunocompetent organ that is richlysupplied with epidermal and dermal dendritic antigenpresenting cells (Schuler et al, 1991; Lenz et al, 1993).Resident skin cells such as keratinocytes and fibroblastsare also capable of synthesizing a range of immunolo-
gically relevant cytokines (McKay and Leigh, 1991), including
particularly IL-1α-like material, which may be recovered in biologically
active amounts from normal human skin in vivo (Gahring et al, 1985;
Hauser et al, 1986; Fincham et al, 1988; Camp et al, 1990). In addition,
T cell infiltrates are a characteristic feature of a range of chronic
inflammatory skin diseases such as psoriasis (Bos et al, 1983), lichen
planus (Mozzanica et al, 1991), photosensitive disorders (Norris et al,
1989a), and atopic dermatitis (Lever et al, 1987), and accumulating
evidence suggests that the T cells play a major pathogenic role in these
diseases. The evidence includes the therapeutic efficacy of cyclosporine
(Van Joost et al, 1988; Norris et al, 1989b; Mozzanica et al, 1991;
Sowden et al, 1991).
Autoimmune skin diseases mediated by pathogenic autoantibodies
are now well recognized and the target antigens are being characterized,
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nature of the response to stratum corneum extracts.
The activity was inhibited by HLA-DR monoclonal
antibody, indicating the presence of antigen or super-
antigen. Tetanus toxoid reactive clones and a purified
protein derivative reactive line failed to respond to the
stratum corneum extracts, indicating that the active
material is not a nonspecific T cell stimulant such as
a cytokine or mitogen. This and the failure of
recombinant interleukin-1α to stimulate peripheral
blood mononuclear cells in concentrations up to 1000 U
per ml, indicate that the activity is not due to
interleukin-1. We propose the hypothesis that antigenic
or superantigenic material is normally sequestered from
the immune system in the epidermis, but induces T
cell activation when released following wounding and
in disease, and that this represents an important and
previously unrecognized pathogenic mechanism. Key
word: antigen. J Invest Dermatol 110:725–729, 1998
e.g., in the blistering diseases pemphigoid and pemphigus (Stanley,
1989); however, it is surprising that autoantigenic T cell epitopes in
skin have not been reported, particularly in the light of the apparent
importance of T cells in chronic inflammatory skin disease and the
competence of the cellular immune system in skin. Candidates for
such epitopes include epidermal keratins, as immunoglobulin G auto-
antibodies reactive with keratin intermediate filament products occur
in normal serum (Hintner et al, 1985) and are elevated in inflammatory
skin disease (Aoki et al, 1989).
We have therefore begun a search for T cell epitopes in human
skin. Previous studies by others have shown that normal human
dander (essentially human hair and stratum corneum) extracts induce
convincing, positive epicutaneous patch test reactions in vivo in patients
with atopic dermatitis (Uehara and Ofuji, 1976; Young et al, 1985),
suggesting the possible presence of autoantigenic or other antigenic
material. We have also consistently observed substantial activation of
peripheral blood mononuclear cells (PBMC) from normal donors by
autologous normal stratum corneum (SC) extracts. Because such activity
has not been described before, we now report the partial biologic
characterization of the stimulatory material. Its purification and deter-
mination of its pathophysiologic relevance are the subjects of further
studies.
MATERIALS AND METHODS
Reagents and media Recombinant interleukin (rIL)-1α (reference 86/678)
was obtained from the National Institute for Biological Standards and Control
(South Mimms, U.K.) and rIL-2 from Eurocetus (Harefield, U.K.). L243
hybridoma was obtained from the American Type Culture Collection (Rock-
ville, MD). Anti-HLA-DR IgG2a monoclonal antibody was purified from bulk
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L243 hybridoma culture supernatants by protein A affinity chromatography.
IgG2a monoclonal antibody M5 (Immunex, Seattle, WA), which binds to
murine type I but not to human IL-1 receptor, was used as L243 isotype
control. [3H]Thymidine (2 Ci per mmol) was obtained from Amersham
(Amersham, U.K.) and purified protein derivative (PPD) of tuberculin from
Evans (Horsham, U.K.). Tetanus toxoid (TT) was used as Tetanus Vaccine BP
in Simple Solution from Wellcome (Beckenham, U.K.). Standard culture
medium (RH10) was RPMI 1640 (ICN-Flow, Thame, U.K.) supplemented
with 10% human AB serum (Sheffield Regional Blood Transfusion Service,
Sheffield, U.K.) and 3 mM glutamine but without antibiotics.
SC extracts Shavings from the beard areas of healthy adult males aged
22–64 were collected daily into freshly cleaned electric razors and stored at
–20°C. Microscopy indicated that the electric razor shavings (ERS) comprised
fragments of hair and a major component of SC squames. ERS were washed
twice in excess acetone for at least 2 h, air dried, and sterilized by 60Co
irradiation (10 kGy). The irradiation dose is that used within the food industry to
eliminate bacteria from foodstuffs (Urbain, 1986). Aliquots of irradiated ERS
were extracted by shaking in 0.146 M NaCl (25–50 mg per ml) for 48 h at
4°C. Supernatants were recovered following centrifugation, filter sterilized
(0.2 µm), and stored at –80°C. The protein concentration of ERS super-
natants was 0.5–0.8 mg per ml (Micro BCA kit, Pierce and Warriner, Chester,
U.K.). SC was also obtained from the washed heel skin of adult volunteers
by using a callus file. Heel SC was washed in acetone, air dried, powdered in
a mortar and pestle, sterilized by irradiation (10 kGy), and extracted by
shaking in 0.146 M NaCl (50 mg per ml) at 4°C for 48 h. Supernatants were
filter sterilized and stored at –80°C. Supernatant protein concentration was
2.4–3.3 mg per ml (Micro BCA kit).
PBMC, T cell lines, and clones PBMC were prepared from heparinized
venous blood of healthy volunteers and subjects with psoriasis and atopic
dermatitis by density gradient centrifugation on Lymphoprep (Nycomed,
Birmingham, U.K.). To prepare ERS and heel SC responsive T cell lines,
PBMC (106 per ml) and ERS or heel SC extracts (10% and 5% vol/vol final
concentrations, respectively) were cultured in 4 ml RH10 and fed with IL-2
(50 U per ml final concentration) every 3 d. After 14 d, cells were restimulated
with SC extracts (respective final concentrations as above) and autologous
irradiated (25 Gy) PBMC (106 per ml). Immunophenotyping was performed
with Dako (Ely, U.K.) monoclonal antibodies and a Becton-Dickinson (Oxford,
U.K.) FACScan. T cell lines were cloned by limiting dilution at 0.3 cells per
Terasaki well. Clones were fed with IL-2 (50 U per ml) every 3 d, and re-
stimulated 2–3 times with SC extract (at the above final concentrations) and
irradiated (25 Gy) autologous PBMC (106 per ml) at 14 d intervals. PPD and
TT responsive T cell lines were also prepared from PBMC using either PPD
(3 µg per ml) or TT (1:2000 dilution), IL-2 (50 U per ml), and autologous,
irradiated PBMC (106 per ml) as above. TT responsive clones were prepared
by limiting dilution from the TT line, using 2–3 re-stimulations with antigen.
The proliferative responses of TT clones and a PPD line to ERS and heel SC
extracts were tested in the presence of autologous, irradiated PBMC. When
necessary, T cell lines and clones were stored under liquid nitrogen before use.
Proliferation assays PBMC (5 3 105 per ml) were cultured in a total
volume of 0.2 ml in the presence of ERS extracts, heel SC extracts, PPD, or
TT for 3–7 d. Cultures were pulsed with [3H]thymidine (1 µCi) for the last
6–18 h, after which cells were harvested onto filter paper via a semiautomatic
Skatron harvester and incorporated radioactivity determined by liquid scintilla-
tion counting. In some experiments PBMC (2–5 3 106 per ml) were cultured
with ERS or heel SC extract for 24 h in a total volume of 2 ml, after which
cells were washed twice in Earle’s balanced salt solution (ICN-Flow, Thame,
U.K.). Thereafter, cells were resuspended in 0.2 ml RH10 at 5 3 105 per ml,
and cultured for a further 4 d before determination of thymidine incorporation.
T cell lines or clones (2 3 105 per ml) were cultured with appropriate antigen
and autologous irradiated (25 Gy) PBMC (5 3 105 per ml) as antigen presenting
cells, and thymidine incorporation determined after 3 d. Results were expressed
as cpm and as stimulation indices (SI, cpm in presence of test material 4 cpm
from control incubations). In certain proliferation assays HLA-DR antibody
(L243), isotype control antibody M5, or rIL-1α were added as described in
the Results.
RESULTS
PBMC and a T cell line proliferate in response to ERS
extract ERS extract induced proliferation of PBMC from normal
volunteers in 3, 5, and 7 d assays, maximum responses as indicated by
SI values occurring at 5 d. Background PBMC proliferation increased
with time, this phenomenon and reduced total cpm in response to
ERS contributing to the lower SI values at 7 d (Fig 1). A 5 d
Figure 1. PBMC proliferate in response to ERS extract. Responses of
PBMC from healthy volunteers H (A) and I (B) to three different dilutions
of ERS extract from healthy volunteer J (30%, 10%, and 1% final concentration)
in 3, 5, and 7 d assays. The figures at the head of each column indicate SI
values and the shaded portions background counts for each assay. Each point
represents the mean of quadruplicate assays.
Figure 2. PBMC from one healthy adult male (J) proliferate in response
to ERS extracts from eight different healthy male donors. The shaded
section of each column shows responses to ERS extracts at 10% final
concentration and the open sections the responses at 30% final concentration
in 5 d assays. Where no open column section is visible, the response at 10%
was greater than at 30%. The figures at the head of each column indicate SI
values. The proliferative response of the donor’s PBMC was greatest to his
own ERS extract (J). Each point is the mean of quadruplicate assays.
incubation time was therefore used in subsequent assays with PBMC.
Extracts of ERS from eight healthy male subjects all induced prolifera-
tion (SI values 5–27) of PBMC from a single healthy male donor (J),
whose response to his own ERS extract was greater than that to
extracts from other donors (Fig 2). Extract of ERS from donor J (30%
vol/vol final concentration) also gave SI values of 2–62 in proliferation
assays with PBMC from 16 different normal donors and patients with
psoriasis or atopic dermatitis (Fig 3). An ERS responsive T cell line
was raised in the presence of IL-2, and two stimulations with ERS
extract and autologous irradiated PBMC, as described. This line
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Figure 3. PBMC from five healthy donors, nine patients with psoriasis,
and two patients with atopic dermatitis, proliferate in response to ERS
extract. ERS extract was from healthy donor J (30% final concentration).
Shaded columns show background responses. The figures at the head of each
open column are SI values. Means of quadruplicate assays are given. *Response
of PBMC from donor J 5 35814 cpm.
proliferated in the presence of ERS extract (10% vol/vol final concentra-
tion) and autologous irradiated PBMC (3 d assay of quadruplicate
samples; mean cpm 44783 and 242 in presence and absence of extract,
respectively; SI 5 185). Fluorescence activated cell sorter analysis of
the ERS responsive T cell line showed that it consisted of 100% CD31
and 93% CD41 cells (% total fluoroscent events).
PBMC from normal donors proliferate in response to extracts
of autologous and allogeneic normal heel SC Heel SC extracts
from two donors were tested at 5%, 15%, and 30% vol/vol final
concentration in standard 5 d assays and in assays in which PBMC
were incubated with the extracts for 24 h, washed, and then re-
incubated in the absence of SC extract for a further 4 d as described
in Materials and Methods. Relatively little proliferation was seen with
assays containing 15% and 30% final concentrations of heel SC for the
full 5 d duration, but marked proliferation occurred at 5% final
concentration (SI values 25–50). These findings indicate the presence
of inhibitory material that was active at higher concentrations of heel
SC extract and obscured proliferative responses when the material was
present for the full duration of the culture. This inhibitory effect of
the higher concentrations of SC extract could be overcome by washing
the PBMC after 24 h, a process that allowed substantial proliferation
at all three extract concentrations (Fig 4). PBMC from five subjects
were also incubated with autologous and allogeneic heel SC extracts
at 30% or 50% vol/vol final concentration for 24 h, followed by
washing and further incubation for a total of 5 d. PBMC showed
substantial proliferative responses to autologous heel SC extracts (SI
5–57). Responses to allogeneic extracts were variable (SI 2–80) but
only in one subject (J) were they consistently greater than the autologous
responses (Fig 5). A heel SC responsive T cell line was raised as
described. Fluorescence activated cell sorter analysis showed 100%
CD31 and 88% CD41 cells (% total fluoroscent events).
Figure 4. PBMC from a healthy subject respond to heel SC extracts.
PBMC were from healthy subject J and heel SC extracts (tested at 5%, 15%,
and 30% final concentrations) were from healthy donors J (A) and I (B). Shaded
columns show responses in assays in which SC extracts were present during
the full 5 d duration. Open columns show results of assays in which PBMC
were washed after 24 h. Figures at the head of each column indicate SI values.
Means of quadruplicate estimations are shown. Similar results were obtained in
a second set of experiments (data not shown).
Figure 5. PBMC from five healthy subjects respond to both autologous
and allogeneic heel SC extract. PBMC and heel SC extracts were prepared
from subjects SI, J, R, C, and SW. PBMC were pulsed with 30% and 50%
vol/vol final concentrations of autologous (j) or allogeneic (u) extract for
24 h, washed, and incubated for a further 4 d before measuring thymidine
incorporation. The initials on the horizontal axis indicate the donor combina-
tions of PBMC and heel SC extract in each incubation, the percentage
showing the vol/vol final concentration of extract that gave the maximum
proliferative response. Each column shows the maximum response (mean of
quintuplicate estimations). Figures at the head of each column indicate SI
values. *cpm 5 82295; **cpm 5 68723; ***cpm 5 59184.
Reactivity of T cell clones and lines to different antigen
preparations T cell clones raised against heel SC extract did not
respond to PPD or TT, but showed concentration related responses
to ERS extract (Fig 6), suggesting the presence of related antigenic
material in the two SC preparations. Three TT responsive clones and
a PPD reactive line did not react to ERS and heel SC extracts (Fig 7),
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Figure 6. Heel reactive T cell clones respond to ERS extract but not
PPD or TT. Proliferative responses of the clones (2 3 105 per ml) were
determined in the presence of autologous, irradiated PBMC (5 3 105 per ml).
ERS extract was incubated with the cells for 3 d and induced concentration
related proliferation of heel SC clone H3j (A), the black shaded columns
showing control responses in the absence of ERS extract. Similar results were
obtained with another heel SC clone, H3L (data not shown). In (B), irradiated
autologous PBMC were pulsed with ERS extract (20% vol/vol final concentra-
tion), PPD (3 µg per ml), or TT (1:2000 dilution) for 24 h and then incubated
with heel SC clone H3f for 3 d. Clone H3f responded to ERS extract, but did
not react to PPD or TT. Mean cpm of quadruplicate assays are shown. The
figures at the head of each column represent SI values. ERS, PBMC, and T
cell clones were all from healthy donor J.
indicating that the active material in the extracts is not a nonspecific
T cell stimulant.
PBMC responses to SC extract are blocked by HLA-DR anti-
body and are not due to IL-1 Proliferative responses of normal
PBMC to ERS and heel SC extracts were reduced or abolished by
addition of anti-HLA-DR antibody (1 and 10 µg per ml). These
concentrations of antibody also reduced responses of PBMC to PPD
(Fig 8). M5 isotype control antibody (up to 50 µg per ml) did not
inhibit PBMC proliferation in response to ERS extract, heel SC
extract, or PPD (data not shown). We have previously reported
the presence in normal SC extracts of biologically active amounts
of IL-1α like material (Fincham et al, 1988; Camp et al, 1990).
Experiments done to determine the contribution of endogenous, skin
derived IL-1 to the PBMC proliferative activity in ERS extracts
showed that rIL-1α (2, 20, 50, 100, 500, and 1000 U per ml) had
little or no effect on PBMC proliferation in quadruplicate 5 d assays
(SI values , 2, data not shown).
DISCUSSION
Aqueous extracts of ERS from healthy donors have been shown
consistently to induce proliferation of PBMC from healthy subjects
and patients with skin diseases. Autologous and allogeneic heel SC
extracts also induce PBMC proliferation, although the presence of
inhibitory material prevents proliferation at higher extract concentra-
tions. This inhibitory effect is overcome by diluting the extract or by
pulsing the PBMC with extract for only 24 h. The nature of the
inhibitory activity has not been established, but may be due to a
mixture of nonspecific toxic substances or a more specific entity such
as transforming growth factor-β (Partridge et al, 1989).
Figure 7. PPD and TT reactive T cell line and clones do not
respond to SC extracts. Proliferative responses of a PPD line and TT clone
(2 3 105 per ml) were determined in 3 d assays in the presence of autologous,
irradiated PBMC (5 3 105 per ml). (A) The PPD reactive T cell line proliferated
in response to PPD (3 µg per ml) but not to TT (1:2000 dilution) or two
concentrations of ERS and heel SC extracts. (B) The TT reactive clone (TTf)
responded greatly to TT (1:2000 dilution), slightly to PPD (3 µg per ml), but
not at all to ERS or heel SC extracts (20% vol/vol final concentration of each,
pulsed for 24 h). Similar results were obtained with two other TT reactive
clones, TTg and TTk (data not shown). The mean cpm of quadruplicate assays
are shown. The figures at the head of each column are SI values. ERS, heel
SC, PBMC, the T cell line, and clones were all from healthy donor J.
PBMC proliferation induced by ERS and heel SC extracts is
abolished by low concentrations of the HLA-DR antibody L243. This
suggests that the extracts contain material with major histocompatibility
complex class II dependent antigenic or superantigenic properties,
although the time course of PBMC proliferative responses to ERS
extract, with maximal responses at 5 d, did not allow ready distinction
between activity likely to be due to superantigen and activity likely to
be due to conventional antigen. The concept that the SC derived
material is antigenic or superantigenic is supported by the finding that
a PPD reactive T cell line and three TT clones did not respond to
ERS and heel SC extracts, and by the demonstration that T cell clones
generated in the presence of SC extract did not respond to other
control antigens. The data showing that heel SC responsive clones
proliferated in the presence of ERS extract suggests that the PBMC
stimulatory material recovered from the different areas of the skin
surface is at least in part similar.
The presence of IL-1α like material in normal human stratum
corneum extracts (Fincham et al, 1988; Camp et al, 1990) raised the
question of whether the T cell stimulatory activity was due to
endogenous IL-1; however, the activity was inhibited by HLA-DR
antibody and rIL-1α was unable to induce PBMC proliferation, even
at high concentrations. Furthermore, ERS and heel SC extracts failed
to activate a PPD reactive T cell line and TT clones, indicating that
the material in the extracts is not a nonspecific T cell stimulant such
as a mitogen or cytokine. These findings indicate that the T cell
stimulatory activity in human SC extracts is not due to IL-1.
Previous reports have suggested the possible presence of T cell
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Figure 8. HLA-DR antibody inhibits responses of PBMC to heel SC
extract, ERS extract, and PPD. PBMC were pulsed with heel SC extract
(20% final concentration) for 24 h and then washed and re-incubated for a
further 4 d before determination of thymidine incorporation (A). ERS extract
(20% vol/vol final concentration, B) and PPD (3 µg per ml final concentration,
C) were incubated with PBMC for 5 d. HLA-DR antibody at 1 and 10 µg
per ml inhibited proliferative responses to heel SC extract (A), ERS extract
(B), and PPD (C), but was ineffective at 0.1 µg per ml. All PBMC and skin
samples were from healthy donor J. Mean cpm from quadruplicate assays
are shown.
activating antigens in epidermis in certain conditions. For example,
epidermal cell suspensions prepared from psoriasis and atopic dermatitis
lesions have an increased capacity to induce antigen presenting cell
dependent proliferation of autologous peripheral blood T cells relative
to samples from normal skin (Baadsgaard et al, 1989; Cooper, 1991).
In addition, autoimmunity against keratinocyte antigens may be induced
during contact sensitization;1 however, to our knowledge this is the
first direct demonstration of spontaneously occurring, extractable,
major histocompatibility complex class II dependent T cell stimulatory
material in human skin. The findings have led to our working
hypothesis that the active material is endogenously or exogenously
derived (super)antigen that is normally sequestered from the cellular
immune system in the epidermis, and against which most subjects will
mount a T cell response, at least in vitro. We propose that membrane
disruption as may occur in wounding or disease leads to release of the
sequestered material, T cell activation, and inflammatory responses of
possible relevance to a range of skin pathologies. The cellular source
of the (super)antigenic material has not been established. Production
of at least some of the components by commensal skin microbes is a
possibility; however, the epidermis is a possible source as we have
shown that supernatants from homogenates of normal human epidermal
sheets, obtained from surgical specimens by a heat separation technique,
also caused PBMC proliferation (data not shown). In contrast, we have
found unexpectedly that T cell stimulatory material is not readily
detectable in aqueous extracts of stratum corneum from psoriatic skin
lesions (Horrocks et al, 1997; unpublished observations). Further work
is now required to clarify the structure, cellular source, biologic
properties, and pathophysiologic relevance of the active substance(s)
1Cruz PD, Dougherty I, Takashima A, Fehr B: In vitro and in vivo evidence
that autoimmunity against keratinocytes is generated during contact sensitization.
J Invest Dermatol 104:570, 1995 (abstr.)
2Hales JM, Camp RDR: T cell stimulatory material in normal human
stratum corneum: isolation of at least eight active components. Br J Dermatol
136:451, 1997 (abstr.)
in normal SC, including the HLA restriction and T cell receptor
repertoire of responding T cells. High performance liquid chromato-
graphy, gel electrophoresis, and nitrocellulose T cell immunoblotting
have demonstrated that the activity in ERS extracts is due to several
components.2 Purification to homogeneity and structural identification
of these components have therefore been undertaken prior to further
study of their biologic properties, as useful biologic characterization is
likely only to be possible with individual, purified components.
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